Z Prime Therapeutics

First-in-class treatments for aggressive, "undruggable" cancers

Company details
Company
Z Prime Therapeutics
Stage
Pre-seed

About

Z Prime Therapeutics

Z Prime Therapeutics is a precision oncology therapeutics biotechnology company developing first-in-class treatments for aggressive, "undruggable" cancers. The company exploit a novel synthetic lethal relationship involving mRNA quality control machinery in cancer cells.

Our Portfolio

Boutique Venture Partners backs authentic founders who transform industries and create new ones in healthcare and life sciences.